Michael Ball, CEO


Victoria, BC




Acquired by US Life Sciences leader, Illumina Inc. in August 2015, GenoLogics gained market recognition as a leading provider of laboratory information management system (LIMS) software specifically designed for genomics and mass spec research in regulated and unregulated labs. GenoLogics products are adopted by more than 120 genomic labs worldwide. The acquisition of GenoLogics strengthens Illumina’s industry-leading portfolio of genetic analysis solutions. GenoLogics was founded in 2002.

Yaletown Partner: Hans Knapp

2005 Yaletown Investment

View GenoLogics News